Understanding Erleada for Prostate Cancer

Erleada, or Apalutamide, is a prescription medication designed to treat prostate cancer that has metastasized and still responds to treatments that reduce testosterone levels. This medication facilitates the possibility of patients attending significant life events, such as sports games with family, despite their health challenges. However, it is critical to recognize that Erleada may lead to serious side effects, including heart disease, stroke, severe skin reactions, falls, fractures, and seizures. Patients should be aware of the potential risks and consult with their healthcare provider to evaluate if Erleada is suitable for their treatment plan.